Evidence map›Paper›PMID 42403489›Full record

ArticleJournal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada2026

Incidence of colonization and infection with carbapenemase-producing Enterobacterales in Toronto and Peel Region, Ontario, 2007-2024.

Angel Xinliu Li, Maxime Lefebvre, Zoe Zhong, Huda Almohri, Irene Armstrong, Mahin Baqi, Kevin R Barker, Sergio Borgia, Brenda L Coleman, Mark Downing and 32 more

Abstract read
In one paragraph

Article in Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Angel Xinliu LiSinai Health System, Toronto, Ontario, Canada.
Maxime LefebvreSinai Health System, Toronto, Ontario, Canada.
Zoe ZhongSinai Health System, Toronto, Ontario, Canada.
Huda AlmohriLifeLabs, Inc., Mississauga, Ontario Canada.
Irene ArmstrongCity of Toronto Public Health Department, Toronto, Ontario, Canada.
Mahin BaqiWilliam Osler Health System, Brampton, Ontario, Canada.
Kevin R BarkerTrillium Health Partners, Mississauga, Ontario, Canada.
Sergio BorgiaWilliam Osler Health System, Brampton, Ontario, Canada.
Brenda L ColemanSinai Health System, Toronto, Ontario, Canada.
Mark DowningDepartment of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Amna FaheemNorth York General Hospital, Toronto, Ontario, Canada.
Wayne L GoldUniversity Health Network, Toronto, Ontario, Canada.
Lee GoneauDynacare, Brampton, Ontario, Canada.
Alainna JamalSinai Health System, Toronto, Ontario, Canada.
Jennie JohnstoneSinai Health System, Toronto, Ontario, Canada.
Christopher KandelSinai Health System, Toronto, Ontario, Canada.
Kevin KatzNorth York General Hospital, Toronto, Ontario, Canada.
Philipp KohlerHOCH, Cantonal Hospital St. Gallen, Division of Infectious Diseases, Infection Prevention and Travel Medicine, St. Gallen, Switzerland.
Julianne V KusDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario Canada.
Tony MazzulliSinai Health System, Toronto, Ontario, Canada.
Roberto G MelanoPan-American Health Organization, Washington, DC, USA.
Samira MubarekaDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario Canada.
Matthew MullerUnity Health, Toronto, Ontario, Canada.
Sarah NayaniSinai Health System, Toronto, Ontario, Canada.
Samir PatelDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario Canada.
Susan M PoutanenSinai Health System, Toronto, Ontario, Canada.
Jeff PowisMichael Garron Hospital, Toronto, Ontario, Canada.
Anu RebbapragadaCanadian Blood Services, Toronto, Ontario, Canada.
Daniel RicciutoLakeridge Health, Oshawa, Ontario, Canada.
David RichardsonWilliam Osler Health System, Brampton, Ontario, Canada.
Andrew E SimorDepartment of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario Canada.
Christie VermeirenShared Hospital Laboratory, North York, Ontario, Canada.
Deborah YamamuraHamilton Regional Laboratory Medicine Program, Hamilton, Ontario, Canada.
Gloria CrowlSinai Health System, Toronto, Ontario, Canada.
Lubna FarooqiSinai Health System, Toronto, Ontario, Canada.
Karen A GreenSinai Health System, Toronto, Ontario, Canada.
Nadia MalikSinai Health System, Toronto, Ontario, Canada.
Mare PejkovskaSinai Health System, Toronto, Ontario, Canada.
Agron PlevneshiSinai Health System, Toronto, Ontario, Canada.
Asfia SultanaSinai Health System, Toronto, Ontario, Canada.
Tamara VikulovaSinai Health System, Toronto, Ontario, Canada.
Allison McGeerSinai Health System, Toronto, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carbapenemase-producing Enterobacterales (CPE) are an urgent public health threat. Monitoring changes in the epidemiology of CPE is critical to the development of action plans against antimicrobial resistance. Methods: The Toronto Invasive Bacterial Diseases Network (TIBDN) has conducted population-based surveillance for CPE in Toronto and Peel Region, Ontario, since its first identification in the population in 2007. Laboratories report all isolates of CPE to the study; confirmation of CPE is by polymerase chain reaction (PCR). Population data are obtained from Statistics Canada. This analysis includes data from 2007 to 2024. Results: The incidence of CPE colonization/infection increased steadily from 0.03/100,000/year to 3.99/100,000/year in 2024, with the exception of the pandemic years (2020-2021). The incidence was higher in Peel Region than Toronto (average IRR 2.2, range 1.8-2.5), with the exception of 2020, when the decrease in Peel Region (IRR 0.51, 95% CI 0.30 to 0.83) was greater than Toronto (IRR 0.86, 95% CI 0.54 to 1.38). Conclusions: The incidence of CPE increased steadily after first detection, although cases decreased during the pandemic. Post-pandemic, substantial increases occurred in both population areas. Screening for colonization can identify patients at increased risk of infection. Improved transmission control programs are needed to mitigate the impact of CPE.

Indexed as

antimicrobial resistancebacterial infectionscarbapenemase-producing Enterobacteralesincidencepopulation-based surveillance

Identifiers

PMID42403489
PMCPMC13331618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.